Form 8-K - Current report:
SEC Accession No. 0001193125-14-234162
Filing Date
2014-06-12
Accepted
2014-06-12 08:06:11
Documents
3
Period of Report
2014-06-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d743136d8k.htm 8-K 15595
2 EX-99.1 d743136dex991.htm EX-99.1 8984
3 GRAPHIC g743136logo.jpg GRAPHIC 4496
  Complete submission text file 0001193125-14-234162.txt   32173
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14656 | Film No.: 14906024
SIC: 2836 Biological Products, (No Diagnostic Substances)